BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Agility, Elekta's Innovative Beam-Shaping Solution for Cancer Treatment, Ships Globally


10/23/2012 12:06:04 PM

ATLANTA, Oct. 22, 2012 /PRNewswire/ -- In the last six months, cancer clinics in 21 countries have accepted delivery of Elekta's Agility*, an innovative, ground-breaking 160-leaf multi-leaf collimator (MLC) that utilizes industry-leading technology to provide faster, more accurate, and more versatile radiation therapy for individuals with cancer.

Agility was recently introduced at Radboud University Nijmegen Medical Center (Nijmegen, Netherlands), where a 48-year-old woman, was treated on September 10.

"Our first use of Agility went perfectly the high leaf speed of Agility has made beam delivery speed much faster, especially with IMRT (Intensity Modulated Radiation Therapy) plans," says Rene Monshouwer, Ph.D., Clinical Physicist at Radboud. "And, comparing the system with Agility to one without Agility, the leaf transmission is lower. Since we began, we have used Agility for 70 patients, encompassing a wide range of cancers throughout the body."

Monshouwer also noted that Agility's low transmission and high-resolution leaves will enable Radboud to use Agility in stereotactic treatments in the coming months.

Legacy Mount Hood Medical Center (Gresham, OR, USA) is the latest site to date to accept shipment of Agility, integrated in a newly acquired Elekta Infinity treatment system. According to Kathryn Panwala, M.D., a radiation oncologist at Legacy, she and her colleagues are eagerly anticipating the patient benefits Agility will bring.

"We're looking forward to the ability to use the five millimeter interdigitating leaves in Agility to allow us to sculpt the radiation dose even more precisely, reduce potential treatment complications and by virtue of the MLC's low transmission reduce unnecessary radiation exposure to normal tissues. We anticipate improved outcomes for our patients with our ability to accurately hypofractionate targets," she says. "We also are looking ahead to doing more complicated treatments at the Mount Hood facility with Agility so SBRT and SRT cases that we had been sending to our downtown facility will be performed at Mount Hood, which is much more convenient for patients. Of course, we also expect treatment times will be faster with the higher speed of leaf movements."

Intelligent beam shaping
Among MLCs, Agility is in class by itself combining leaf speeds that are twice as fast as conventional beam-shaping devices. The 160 leaves of Agility are 5 mm in width at isocenter and are capable of interdigitation to enable treatment of island fields and multiple targets in a single session. Rubicon optical leaf positioning technology improves accuracy and increases the reliability and seamlessness of beam shaping, and the exceptionally low leaf transmission of less than 0.5 percent enhances treatment delivery while reducing integral dose. The integrated whole results in a sophisticated, multi-functional beam-shaping solution.

Learn more about Agility at www.elekta.com/agility.

*Agility is not available for sale or distribution in all markets. Please contact the local Elekta representative for details.

For further information, please contact:
Johan Andersson Melbi, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta



Read at BioSpace.com

Elekta
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES